Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Characteristics and Outcomes of Young Children Hospitalized With Laboratory-confirmed Influenza or Respiratory Syncytial Virus in Ontario, Canada, 2009-2014.

Buchan SA, Chung H, Karnauchow T, McNally JD, Campitelli MA, Gubbay JB, Katz K, McGeer AJ, Richardson DC, Richardson SE, Simor A, Smieja M, Zahariadis G, Tran D, Crowcroft NS, Rosella LC, Kwong JC.

Pediatr Infect Dis J. 2019 Apr;38(4):362-369. doi: 10.1097/INF.0000000000002164.

PMID:
30882725
2.

Population risk and burden of health behavioral-related all-cause, premature, and amenable deaths in Ontario, Canada: Canadian Community Health Survey-linked mortality files.

Rosella LC, Kornas K, Huang A, Grant L, Bornbaum C, Henry D.

Ann Epidemiol. 2019 Jan 25. pii: S1047-2797(18)30783-X. doi: 10.1016/j.annepidem.2019.01.009. [Epub ahead of print]

PMID:
30803751
3.

Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.

Wilson SE, Rosella LC, Wang J, Renaud A, Le Saux N, Crowcroft NS, Desai S, Harris T, Bolotin S, Gubbay J, Deeks SL.

Vaccine. 2019 Feb 9. pii: S0264-410X(19)30146-X. doi: 10.1016/j.vaccine.2019.01.061. [Epub ahead of print]

PMID:
30765171
4.

Putting a Population Health Lens to Multimorbidity in Ontario.

Rosella L, Kornas K.

Healthc Q. 2018 Oct;21(3):8-11. doi: 10.12927/hcq.2018.25709.

PMID:
30741147
5.

Neighbourhood walkability and the incidence of diabetes: an inverse probability of treatment weighting analysis.

Booth GL, Creatore MI, Luo J, Fazli GS, Johns A, Rosella LC, Glazier RH, Moineddin R, Gozdyra P, Austin PC.

J Epidemiol Community Health. 2019 Apr;73(4):287-294. doi: 10.1136/jech-2018-210510. Epub 2019 Jan 29.

PMID:
30696690
6.

Survival and Health Care Use After Feeding Tube Placement in Children With Neurologic Impairment.

Nelson KE, Rosella LC, Mahant S, Cohen E, Guttmann A.

Pediatrics. 2019 Feb;143(2). pii: e20182863. doi: 10.1542/peds.2018-2863.

PMID:
30679378
7.

Assessment of Long-term Follow-up of Randomized Trial Participants by Linkage to Routinely Collected Data: A Scoping Review and Analysis.

Fitzpatrick T, Perrier L, Shakik S, Cairncross Z, Tricco AC, Lix L, Zwarenstein M, Rosella L, Henry D.

JAMA Netw Open. 2018 Dec 7;1(8):e186019. doi: 10.1001/jamanetworkopen.2018.6019.

8.

Accuracy of health administrative data to identify cases of reportable travel or migration-related infectious diseases in Ontario, Canada.

Savage RD, Rosella LC, Crowcroft NS, Horn M, Khan K, Varia M.

PLoS One. 2018 Nov 7;13(11):e0207030. doi: 10.1371/journal.pone.0207030. eCollection 2018.

9.

Death and Chronic Disease Risk Associated With Poor Life Satisfaction: A Population-Based Cohort Study.

Rosella LC, Fu L, Buajitti E, Goel V.

Am J Epidemiol. 2019 Feb 1;188(2):323-331. doi: 10.1093/aje/kwy245.

10.

Effects of behavioural risk factors on high-cost users of healthcare: a population-based study.

Alberga A, Holder L, Kornas K, Bornbaum C, Rosella L.

Can J Public Health. 2018 Aug;109(4):441-450. doi: 10.17269/s41997-018-0127-5. Epub 2018 Sep 19.

11.
12.

Characteristics and Outcomes of Young Children Hospitalized with Laboratory-Confirmed Influenza or Respiratory Syncytial Virus in Ontario, Canada, 2009-2014.

Buchan SA, Chung H, Karnauchow T, McNally JD, Campitelli MA, Gubbay JB, Katz K, McGeer AJ, Richardson DC, Richardson SE, Simor A, Smieja M, Zahariadis G, Tran D, Crowcroft NS, Rosella LC, Kwong JC.

Pediatr Infect Dis J. 2018 Aug 27. doi: 10.1097/INF.0000000000002164. [Epub ahead of print]

PMID:
30153230
13.

Joint effects of serum vitamin D insufficiency and periodontitis on insulin resistance, pre-diabetes, and type 2 diabetes: results from the National Health and Nutrition Examination Survey (NHANES) 2009-2010.

Zuk AM, Quiñonez CR, Saarela O, Demmer RT, Rosella LC.

BMJ Open Diabetes Res Care. 2018 Jul 23;6(1):e000535. doi: 10.1136/bmjdrc-2018-000535. eCollection 2018.

14.

Regional Inequalities in All-Cause and Premature Mortality in Ontario.

Henry D, Buajitti E, Rosella L.

Healthc Pap. 2018 Jan;17(3):28-34. doi: 10.12927/hcpap.2018.25504.

PMID:
30052183
15.

Development and validation of a cardiovascular disease risk-prediction model using population health surveys: the Cardiovascular Disease Population Risk Tool (CVDPoRT).

Manuel DG, Tuna M, Bennett C, Hennessy D, Rosella L, Sanmartin C, Tu JV, Perez R, Fisher S, Taljaard M.

CMAJ. 2018 Jul 23;190(29):E871-E882. doi: 10.1503/cmaj.170914.

16.

Limitations of administrative data to identify measles cases in Ontario, Canada: a cautionary tale.

Johnson C, Chen C, Rosella L, Rilkoff H, Marchand-Austin A, Gubbay JB, Kozlowski T, Deeks SL, Mazzulli T, Crowcroft N.

Can J Public Health. 2018 Feb;109(1):3-7. doi: 10.17269/s41997-018-0021-1. Epub 2018 Feb 26.

PMID:
29981059
17.

Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada.

Johnstone J, Chen C, Rosella L, Adomako K, Policarpio ME, Lam F, Prematunge C, Garber G; Ontario VRE Investigators.

Am J Infect Control. 2018 Nov;46(11):1266-1271. doi: 10.1016/j.ajic.2018.05.003. Epub 2018 Jun 11.

18.

The association between food insecurity and incident type 2 diabetes in Canada: A population-based cohort study.

Tait CA, L'Abbé MR, Smith PM, Rosella LC.

PLoS One. 2018 May 23;13(5):e0195962. doi: 10.1371/journal.pone.0195962. eCollection 2018.

19.

The Relationship Between Life Satisfaction and Healthcare Utilization: A Longitudinal Study.

Goel V, Rosella LC, Fu L, Alberga A.

Am J Prev Med. 2018 Aug;55(2):142-150. doi: 10.1016/j.amepre.2018.04.004. Epub 2018 May 18.

PMID:
29779906
20.

Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs.

Henry D, Stehlik P, Rosella L.

Int J Epidemiol. 2018 Apr 1;47(2):675-676. doi: 10.1093/ije/dyy051. No abstract available.

PMID:
29618002
21.

A Canadian Population-Based Cohort to the Study Cost and Burden of Surgically Resected Hidradenitis Suppurativa.

Mehdizadeh A, Rosella L, Alavi A, Sibbald G, Farzanfar D, Hazrati A, Vernich L, Laporte A, Hu H, Bashash M.

J Cutan Med Surg. 2018 May/Jun;22(3):312-317. doi: 10.1177/1203475418763536. Epub 2018 Mar 11.

PMID:
29528753
22.

Accumulation Of Chronic Conditions At The Time Of Death Increased In Ontario From 1994 To 2013.

Rosella L, Kornas K, Huang A, Bornbaum C, Henry D, Wodchis WP.

Health Aff (Millwood). 2018 Mar;37(3):464-472. doi: 10.1377/hlthaff.2017.1150.

PMID:
29505380
23.

Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs.

Stehlik P, Rosella L, Henry D.

Int J Epidemiol. 2018 Apr 1;47(2):362-367. doi: 10.1093/ije/dyx284. No abstract available.

PMID:
29390133
24.

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB.

N Engl J Med. 2018 Jan 25;378(4):345-353. doi: 10.1056/NEJMoa1702090.

25.

Development and validation of a population based risk algorithm for obesity: The Obesity Population Risk Tool (OPoRT).

Lebenbaum M, Espin-Garcia O, Li Y, Rosella LC.

PLoS One. 2018 Jan 18;13(1):e0191169. doi: 10.1371/journal.pone.0191169. eCollection 2018.

26.

How Can We Keep Immigrant Travelers Healthy? Health Challenges Experienced by Canadian South Asian Travelers Visiting Friends and Relatives.

Savage RD, Rosella LC, Crowcroft NS, Arneja J, de Villa E, Horn M, Khan K, Varia M.

Qual Health Res. 2018 Mar;28(4):610-623. doi: 10.1177/1049732317746381. Epub 2017 Dec 14.

PMID:
29239271
27.

Predicting High Health Care Resource Utilization in a Single-payer Public Health Care System: Development and Validation of the High Resource User Population Risk Tool.

Rosella LC, Kornas K, Yao Z, Manuel DG, Bornbaum C, Fransoo R, Stukel T.

Med Care. 2018 Oct;56(10):e61-e69. doi: 10.1097/MLR.0000000000000837.

28.

Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.

Buchan SA, Chung H, Campitelli MA, Crowcroft NS, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson D, Richardson SE, Rosella LC, Simor A, Smieja M, Tran D, Zahariadis G, Kwong JC.

PLoS One. 2017 Nov 17;12(11):e0187834. doi: 10.1371/journal.pone.0187834. eCollection 2017.

29.

"We Have a Right to Know": Exploring Consumer Opinions on Content, Design and Acceptability of Enhanced Alcohol Labels.

Vallance K, Romanovska I, Stockwell T, Hammond D, Rosella L, Hobin E.

Alcohol Alcohol. 2018 Jan 1;53(1):20-25. doi: 10.1093/alcalc/agx068.

PMID:
29016716
30.

Testing the Efficacy of Alcohol Labels with Standard Drink Information and National Drinking Guidelines on Consumers' Ability to Estimate Alcohol Consumption.

Hobin E, Vallance K, Zuo F, Stockwell T, Rosella L, Simniceanu A, White C, Hammond D.

Alcohol Alcohol. 2018 Jan 1;53(1):3-11. doi: 10.1093/alcalc/agx052.

PMID:
29016708
31.

Characterising violent deaths of undetermined intent: a population-based study, 1999-2012.

Lachaud J, Donnelly P, Henry D, Kornas K, Fitzpatrick T, Calzavara A, Bornbaum C, Rosella L.

Inj Prev. 2018 Dec;24(6):424-430. doi: 10.1136/injuryprev-2017-042376. Epub 2017 Oct 6.

32.

Trends in standardized mortality among individuals with schizophrenia, 1993-2012: a population-based, repeated cross-sectional study.

Gatov E, Rosella L, Chiu M, Kurdyak PA.

CMAJ. 2017 Sep 18;189(37):E1177-E1187. doi: 10.1503/cmaj.161351.

33.

Consumers' Response to an On-Shelf Nutrition Labelling System in Supermarkets: Evidence to Inform Policy and Practice.

Hobin E, Bollinger B, Sacco J, Liebman E, Vanderlee L, Zuo F, Rosella L, L'abbe M, Manson H, Hammond D.

Milbank Q. 2017 Sep;95(3):494-534. doi: 10.1111/1468-0009.12277.

34.

A population-based study of homicide deaths in Ontario, Canada using linked death records.

Lachaud J, Donnelly PD, Henry D, Kornas K, Calzavara A, Bornbaum C, Rosella L.

Int J Equity Health. 2017 Jul 24;16(1):133. doi: 10.1186/s12939-017-0632-9.

35.

Big Data and Population Health: Focusing on the Health Impacts of the Social, Physical, and Economic Environment.

Hu H, Galea S, Rosella L, Henry D.

Epidemiology. 2017 Nov;28(6):759-762. doi: 10.1097/EDE.0000000000000711.

PMID:
28682850
36.

Diabetes risk reduction in primary care: Evaluation of the Ontario Primary Care Diabetes Prevention Program.

Hillmer M, Sandoval GA, Elliott JA, Jain M, Barker T, Prisniak A, Astley S, Rosella L.

Can J Public Health. 2017 Jun 16;108(2):e176-e184. doi: 10.17269/cjph.108.5287.

PMID:
28621654
37.

Socioeconomic gradients in all-cause, premature and avoidable mortality among immigrants and long-term residents using linked death records in Ontario, Canada.

Khan AM, Urquia M, Kornas K, Henry D, Cheng SY, Bornbaum C, Rosella LC.

J Epidemiol Community Health. 2017 Jul;71(7):625-632. doi: 10.1136/jech-2016-208525. Epub 2017 Mar 13.

38.

The cost of diabetes in Canada over 10 years: applying attributable health care costs to a diabetes incidence prediction model.

Bilandzic A, Rosella L.

Health Promot Chronic Dis Prev Can. 2017 Feb;37(2):49-53. English, French.

39.

A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions.

Nanwa N, Sander B, Krahn M, Daneman N, Lu H, Austin PC, Govindarajan A, Rosella LC, Cadarette SM, Kwong JC.

PLoS One. 2017 Mar 3;12(3):e0172410. doi: 10.1371/journal.pone.0172410. eCollection 2017.

40.

Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data.

Fitzpatrick T, Perrier L, Tricco AC, Straus SE, Jüni P, Zwarenstein M, Lix LM, Smith M, Rosella LC, Henry DA.

BMJ Open. 2017 Feb 17;7(2):e013770. doi: 10.1136/bmjopen-2016-013770.

41.

Evaluation of the ability of standardized supports to improve public health response to syndromic surveillance for respiratory diseases in Canada.

Rivera LA, Li Y, Savage RD, Crowcroft NS, Bolotin S, Rosella LC, Lou W, Hopkins J, Gemmill I, Johnson I.

BMC Public Health. 2017 Feb 15;17(1):199. doi: 10.1186/s12889-017-4073-6.

42.

Narrowing mortality gap between men and women over two decades: a registry-based study in Ontario, Canada.

Rosella LC, Calzavara A, Frank JW, Fitzpatrick T, Donnelly PD, Henry D.

BMJ Open. 2016 Nov 14;6(11):e012564. doi: 10.1136/bmjopen-2016-012564.

43.

The association between undiagnosed glycaemic abnormalities and cardiometabolic risk factors with periodontitis: results from 2007-2009 Canadian Health Measures Survey.

Zuk A, Quiñonez C, Lebenbaum M, Rosella LC.

J Clin Periodontol. 2017 Feb;44(2):132-141. doi: 10.1111/jcpe.12684. Epub 2017 Jan 24.

PMID:
28028834
44.

Residents of highly walkable neighbourhoods in Canadian urban areas do substantially more physical activity: a cross-sectional analysis.

Thielman J, Manson H, Chiu M, Copes R, Rosella LC.

CMAJ Open. 2016 Dec 1;4(4):E720-E728. doi: 10.9778/cmajo.20160068. eCollection 2016 Oct-Dec.

45.

Assessing the risk of intussusception and rotavirus vaccine safety in Canada.

Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, Crowcroft NS, Halperin SA, Desai S, Naus M, Sanford CJ, Mahmud SM, Deeks SL.

Hum Vaccin Immunother. 2017 Mar 4;13(3):703-710. doi: 10.1080/21645515.2016.1240846. Epub 2016 Nov 11.

46.

The impact of access to health services on prediabetes awareness: A population-based study.

Campbell TJ, Alberga A, Rosella LC.

Prev Med. 2016 Dec;93:7-13. doi: 10.1016/j.ypmed.2016.09.008. Epub 2016 Sep 6.

PMID:
27612580
47.

Effectiveness of pertussis vaccination and duration of immunity.

Schwartz KL, Kwong JC, Deeks SL, Campitelli MA, Jamieson FB, Marchand-Austin A, Stukel TA, Rosella L, Daneman N, Bolotin S, Drews SJ, Rilkoff H, Crowcroft NS.

CMAJ. 2016 Nov 1;188(16):E399-E406. doi: 10.1503/cmaj.160193. Epub 2016 Sep 26.

48.

Measuring Burden of Unhealthy Behaviours Using a Multivariable Predictive Approach: Life Expectancy Lost in Canada Attributable to Smoking, Alcohol, Physical Inactivity, and Diet.

Manuel DG, Perez R, Sanmartin C, Taljaard M, Hennessy D, Wilson K, Tanuseputro P, Manson H, Bennett C, Tuna M, Fisher S, Rosella LC.

PLoS Med. 2016 Aug 16;13(8):e1002082. doi: 10.1371/journal.pmed.1002082. eCollection 2016 Aug.

49.

Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.

Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL.

Vaccine. 2016 Sep 7;34(39):4678-4683. doi: 10.1016/j.vaccine.2016.08.020. Epub 2016 Aug 12.

50.

Impact of pharmacist administration of influenza vaccines on uptake in Canada.

Buchan SA, Rosella LC, Finkelstein M, Juurlink D, Isenor J, Marra F, Patel A, Russell ML, Quach S, Waite N, Kwong JC; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group.

CMAJ. 2017 Jan 30;189(4):E146-E152. doi: 10.1503/cmaj.151027. Epub 2016 Aug 8.

Supplemental Content

Loading ...
Support Center